ATE443053T1 - Als inhibitoren von erbb-tyrosinkinase verwendete chinazoleinderivate - Google Patents

Als inhibitoren von erbb-tyrosinkinase verwendete chinazoleinderivate

Info

Publication number
ATE443053T1
ATE443053T1 AT06820361T AT06820361T ATE443053T1 AT E443053 T1 ATE443053 T1 AT E443053T1 AT 06820361 T AT06820361 T AT 06820361T AT 06820361 T AT06820361 T AT 06820361T AT E443053 T1 ATE443053 T1 AT E443053T1
Authority
AT
Austria
Prior art keywords
quinazolein
tyrosinkinase
erbb
inhibitors
derivatives used
Prior art date
Application number
AT06820361T
Other languages
English (en)
Inventor
Robert Hugh Bradbury
Bernard Christophe Barlaam
Richard Ducray
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE443053T1 publication Critical patent/ATE443053T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Cold Air Circulating Systems And Constructional Details In Refrigerators (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT06820361T 2005-12-02 2006-11-29 Als inhibitoren von erbb-tyrosinkinase verwendete chinazoleinderivate ATE443053T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05292551 2005-12-02
PCT/GB2006/004451 WO2007063293A1 (en) 2005-12-02 2006-11-29 Quinazoleine derivatives used as inhibitors of erbb tyrosine kinase

Publications (1)

Publication Number Publication Date
ATE443053T1 true ATE443053T1 (de) 2009-10-15

Family

ID=37685073

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06820361T ATE443053T1 (de) 2005-12-02 2006-11-29 Als inhibitoren von erbb-tyrosinkinase verwendete chinazoleinderivate

Country Status (7)

Country Link
US (1) US20090029968A1 (de)
EP (1) EP1960371B1 (de)
JP (1) JP2009517451A (de)
CN (1) CN101321739A (de)
AT (1) ATE443053T1 (de)
DE (1) DE602006009304D1 (de)
WO (1) WO2007063293A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE395346T1 (de) 2003-09-16 2008-05-15 Astrazeneca Ab Chinazolinderivate als tyrosinkinaseinhibitoren
GB0322409D0 (en) * 2003-09-25 2003-10-29 Astrazeneca Ab Quinazoline derivatives
GB0326459D0 (en) 2003-11-13 2003-12-17 Astrazeneca Ab Quinazoline derivatives
DE602005010824D1 (de) 2004-02-03 2008-12-18 Astrazeneca Ab Chinazolinderivate
ATE501148T1 (de) * 2004-12-14 2011-03-15 Astrazeneca Ab Pyrazolopyrimidinverbindungen als antitumormittel
EA202190749A1 (ru) 2018-09-10 2021-07-09 Мирати Терапьютикс, Инк. Способы комбинированной терапии

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5538325A (en) * 1978-09-11 1980-03-17 Sankyo Co Ltd 4-anilinoquinazoline derivative and its preparation
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
GB2160201B (en) * 1984-06-14 1988-05-11 Wyeth John & Brother Ltd Quinazoline and cinnoline derivatives
US4921863A (en) * 1988-02-17 1990-05-01 Eisai Co., Ltd. Cyclic amine derivatives
CA1340821C (en) * 1988-10-06 1999-11-16 Nobuyuki Fukazawa Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components
US5721237A (en) * 1991-05-10 1998-02-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
US5747498A (en) * 1996-05-28 1998-05-05 Pfizer Inc. Alkynyl and azido-substituted 4-anilinoquinazolines
US6046206A (en) * 1995-06-07 2000-04-04 Cell Pathways, Inc. Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
GB9624482D0 (en) * 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
CA2216169C (en) * 1996-01-31 2007-01-23 Gist-Brocades B.V. Use of compositions comprising stabilized biologically effective compounds
US6004967A (en) * 1996-09-13 1999-12-21 Sugen, Inc. Psoriasis treatment with quinazoline compounds
US5929080A (en) * 1997-05-06 1999-07-27 American Cyanamid Company Method of treating polycystic kidney disease
US6384223B1 (en) * 1998-07-30 2002-05-07 American Home Products Corporation Substituted quinazoline derivatives
US6297258B1 (en) * 1998-09-29 2001-10-02 American Cyanamid Company Substituted 3-cyanoquinolines
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
CA2361174C (en) * 1999-02-27 2009-10-27 Boehringer Ingelheim Pharma Kg 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
US6080747A (en) * 1999-03-05 2000-06-27 Hughes Institute JAK-3 inhibitors for treating allergic disorders
UA73993C2 (uk) * 2000-06-06 2005-10-17 Астразенека Аб Хіназолінові похідні для лікування пухлин та фармацевтична композиція
US20020082270A1 (en) * 2000-08-26 2002-06-27 Frank Himmelsbach Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases
US6562319B2 (en) * 2001-03-12 2003-05-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
EP1396488A1 (de) * 2001-05-23 2004-03-10 Mitsubishi Pharma Corporation Kondensierte heterocyclische verbindung und deren medizinische verwendung
GB0126433D0 (en) * 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
US20050043336A1 (en) * 2001-11-03 2005-02-24 Hennequin Laurent Francois Andre Quinazoline derivatives as antitumor agents
TWI324597B (en) * 2002-03-28 2010-05-11 Astrazeneca Ab Quinazoline derivatives
US6924285B2 (en) * 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
GB0309009D0 (en) * 2003-04-22 2003-05-28 Astrazeneca Ab Quinazoline derivatives
GB0309850D0 (en) * 2003-04-30 2003-06-04 Astrazeneca Ab Quinazoline derivatives
GB0317665D0 (en) * 2003-07-29 2003-09-03 Astrazeneca Ab Qinazoline derivatives
UY28441A1 (es) * 2003-07-29 2005-02-28 Astrazeneca Ab Derivados de quinazolina
ATE395346T1 (de) * 2003-09-16 2008-05-15 Astrazeneca Ab Chinazolinderivate als tyrosinkinaseinhibitoren
AU2004272346A1 (en) * 2003-09-16 2005-03-24 Astrazeneca Ab Quinazoline derivatives
GB0321648D0 (en) * 2003-09-16 2003-10-15 Astrazeneca Ab Quinazoline derivatives
CN1882570B (zh) * 2003-09-19 2010-12-08 阿斯利康(瑞典)有限公司 喹唑啉衍生物
WO2005030757A1 (en) * 2003-09-25 2005-04-07 Astrazeneca Ab Quinazoline derivatives
GB0322409D0 (en) * 2003-09-25 2003-10-29 Astrazeneca Ab Quinazoline derivatives
GB0326459D0 (en) * 2003-11-13 2003-12-17 Astrazeneca Ab Quinazoline derivatives
DE602005010824D1 (de) * 2004-02-03 2008-12-18 Astrazeneca Ab Chinazolinderivate
BRPI0511741A (pt) * 2004-06-04 2008-01-02 Astrazeneca Ab derivado de quinazolina ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, processo para a preparação de um derivado de quinazolina ou de um sal farmaceuticamente aceitável do mesmo

Also Published As

Publication number Publication date
HK1122795A1 (en) 2009-05-29
WO2007063293A1 (en) 2007-06-07
JP2009517451A (ja) 2009-04-30
DE602006009304D1 (de) 2009-10-29
EP1960371A1 (de) 2008-08-27
CN101321739A (zh) 2008-12-10
EP1960371B1 (de) 2009-09-16
US20090029968A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
NO20061321L (no) Kinazolinderivater som tyrosin kinase inhibitorer
DE602004022404D1 (de) 4-anilino-chinazolin-derivate als proliferationshemmende mittel
NO20061320L (no) Kinazolinderivater som antitumor agenter
DE60309848D1 (de) Purinderivate als kinaseinhibitoren
NI201000059A (es) Inhibidores de la cinasa c-fms.
ECSP12007067A (es) Derivados de quinazolinona útiles como antagonistas vanilloides
SG163585A1 (en) Melanocortin receptor ligands
ATE400567T1 (de) Kinaseinhibitoren
UY28610A1 (es) Derivados de quinazolina
ATE438641T1 (de) Chinazolinderivate als inhibitoren von egf und/oder erbb2-rezeptortyrosinkinase
CY1111691T1 (el) Ενισχυτης της δραστικοτητας πρωτεϊνοκινασης c περιεχων παραγωγο αλκυλαιθερος ή αλας αυτου
UA107689C2 (xx) ПОХІДНІ 3,4,4A,10B-ТЕТРАГІДРО-1H-ТІОПІРАНО$4, 3-c]ІЗОХІНОЛІНУ
MA32296B1 (fr) Derives de piperidine 3,4-substitues comme inhibiteurs de la renine
ATE438642T1 (de) Chinazolinderivate als egf- und/oder erbb2- tyrosinkinaseinhibitoren
EA200901504A1 (ru) Производные пиразолона, как ингибиторы pde4
TW200745090A (en) Chemical compounds
ATE443053T1 (de) Als inhibitoren von erbb-tyrosinkinase verwendete chinazoleinderivate
DE602005026865D1 (de) Pyrazolopyrimidinverbindungen als antitumormittel
DE602005005024D1 (de) Substituierte thieno- und thiazoloä2,3-düpyrimidine und ä2,3-cüpyridine als inhibitoren von tie2
ATE548364T1 (de) Aminopyrazolkinasehemmer
ATE404554T1 (de) Pyrimidinderivate zur verwendung als antikrebsmittel
EA200701626A1 (ru) Новые 6-пиридилфенантридины
UY28518A1 (es) Derivados de quinazolina
ATE421510T1 (de) Kompetitive atp-kinasehemmer
TH75064A (th) อนุพันธ์ควินาโซลีน

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties